No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Delayed receipt of adjuvant hormone therapy is associated with worse survival in HR⁺, ERBB2- breast cancer

byTeddy Guo

March 8, 2022

in StudyGraphics

Reading Time: 1 min read

Clinically important troponin I threshold for mortality after cardiac surgery

RelatedReports

Cardiology

Risk of cardiovascular mortality in patients with gastric cancer

November 10, 2025

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Chronic Disease

2 Minute Medicine: Pharma Roundup – Breakthrough ALS gene therapy, new adult pneumonia vaccine, needle-free obesity treatment, and Pfizer’s business overhaul [October 28, 2025]

October 29, 2025

Lessons from real-world implementation of lung cancer screening

Chronic Disease

Ifinatamab Deruxtecan in Patients With Extensive-Stage Small-Cell Lung Cancer: Primary Analysis of the Phase 2 IDeate-Lung01 Trial

October 22, 2025

Population-based risk factors and geographical trends identified for vitiligo

Oncology

Increasing cancer incidence rates in younger and older adults worldwide

October 20, 2025

Parental nonmedical prescription opioid use linked to adolescent use

Intensive blood pressure control associated with increased cerebral blood flow in patients with hypertension – the SPRINT trial

Blindness and visual impairment decreasing worldwide

Faricimab may improve visual acuity in patients with diabetic macular edema

#VisualAbstract: Endotracheal intubation offers no benefit over supraglottic airway in patients with out-of-hospital return of spontaneous circulation

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports